Who are Petra Pharma's investors?

Petra Pharma's investors include Pfizer Venture Investments, 180 Degree Capital, AbbVie, Alexandria, ARCH Venture Partners, Johnson & Johnson Innovation – JJDC.

How much funding has Petra Pharma raised?

Petra Pharma has disclosed $58.8M raised across 2 rounds.

Where is Petra Pharma headquartered?

Petra Pharma is headquartered in New York, US.

Petra Pharma

New York, US · Founded 2015 · Delaware corporation · 6 known investors

Find your way into Petra Pharma

Biotech

Founders & leadership

Brian O'CallaghanExecutive

David RenasExecutive

Albert YuNamed on SEC filing

David McElligottNamed on SEC filing

Board

Steve Gillis Board directorManaging Director at ARCH Venture Partners

Joel MarcusBoard directorExecutive Chairman & Founder at Alexandria

Barbara DaltonBoard director

M. Johnston ErwinBoard director

Thong LeBoard director

Paul SekhriBoard director

Investors · 6

Pfizer Venture Investmentslisted by Pfizer Venture Investments$5M – $20M

How we know: Pfizer Venture Investments's portfolio page · funding news · Not right? Tell us

180 Degree CapitalreportedMenlo Park

How we know: funding news · Not right? Tell us

AbbViereportedCambridge · $300K – $3M

How we know: funding news · Not right? Tell us

AlexandriareportedPasadena

How we know: funding news · Not right? Tell us

ARCH Venture PartnersreportedChicago · $50K – $250M

How we know: funding news · Not right? Tell us

Johnson & Johnson Innovation – JJDCreportedNew Brunswick

How we know: funding news · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$58.8M disclosed across 2 rounds · 2015–2018

▶$27.5MraisedMar 2020 · 10 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Steve GillisDirector
M. Johnston ErwinDirector
Barbara DaltonDirector
Jenna FogerDirector
Paul SekhriDirector
Thong LeDirector, Promoter
David McElligottExecutive Officer, Promoter
David RenasExecutive Officer
Albert YuExecutive Officer
Lindsay RaylePromoter
David SchubertPromoter
Brian O'CallaghanExecutive Officer, Director

Offering amount: $27.5M
Amount sold: $27.5M
First sale: Aug 2018
Incorporated: Corporation, Delaware, 2015
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$31.2MraisedJan 2018 · 13 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Lindsay RaylePromoter
Paul SekhriDirector
David SchubertPromoter
Steve GillisDirector
Joel MarcusDirector
Barbara DaltonDirector
Brian O'CallaghanExecutive Officer, Director
M. Johnston ErwinDirector
David RenasExecutive Officer
Albert YuExecutive Officer, Promoter
David McElligottExecutive Officer, Promoter
Thong LeDirector, Promoter

Offering amount: $48.3M
Amount sold: $31.2M
First sale: Dec 2015
Incorporated: Corporation, Delaware, 2015
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Petra Pharma's investors?: Petra Pharma's investors include Pfizer Venture Investments, 180 Degree Capital, AbbVie, Alexandria, ARCH Venture Partners, Johnson & Johnson Innovation – JJDC.
How much funding has Petra Pharma raised?: Petra Pharma has disclosed $58.8M raised across 2 rounds.
Where is Petra Pharma headquartered?: Petra Pharma is headquartered in New York, US.